Marshall Wace’s Apollo Endosurgery, Inc. APEN Stock Holding History

Marshall Wace’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-58,923	Closed	-$215K	–	3969
2022 Q2	$215K	Sell	58,923 -18,503	-24%	-$87.5K	﹤0.01%	3149
2022 Q1	$468K	Sell	77,426 -27,240	-26%	-$166K	﹤0.01%	2807
2021 Q4	$882K	Sell	104,666 -44,356	-30%	-$387K	﹤0.01%	2533
2021 Q3	$1.35M	Buy	149,022 +8,198	+6%	+$70.5K	0.01%	1812
2021 Q2	$1.14M	Sell	140,824 -234,475	-62%	-$1.61M	0.01%	1750
2021 Q1	$2.07M	Buy	+375,299	New	+$1.86M	0.01%	1311

Other funds holding APEN

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Marshall Wace's APEN Position: Q3 2022 in Review

Marshall Wace sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2022, closing a stake of 58,923 shares — an estimated $215K sold.

Marshall Wace first reported a position in APEN in Q1 2021 and held it in 6 quarters. The position peaked at $2.07M in Q1 2021. 53 funds tracked by Wall St. Rank hold APEN as of Q3 2022.

Marshall Wace reported no remaining Apollo Endosurgery, Inc. position as of Q3 2022 after selling out during the quarter.
Marshall Wace sold 58,923 Apollo Endosurgery, Inc. shares in Q3 2022, an estimated $215K.
Marshall Wace first reported a position in Apollo Endosurgery, Inc. in Q1 2021 and held it in 6 quarters.
Marshall Wace's Apollo Endosurgery, Inc. position peaked at $2.07M in Q1 2021.
53 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.